socalTechnews
 
Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•
    Search News
    Wednesday, March 19, 2008

    Xencor Names Chairman
    Monrovia, California-based Xencor, which develops protein and antibody therapeutics, said Wednesday that it has appointed David R. King as the Chairman of its board of directors. Xencor develops biotherapeutics are used to improve antibody effectiveness for treating cancer, inflammation, and autoimmune diseases. King joins the firm from BioRexis Pharmacueticals, where he was co-founder and CEO; King has also served at Morgan, Lewis & Bockies LLP, Principia Pharmaceutical corporation, Delsys Pharmaceutical Corp. and BioRexis.
    posted on Wednesday, March 19, 2008

    Related companies:
    Xencor

    Related stories:
    > Xencor Gets $6M
    > Xencor In Deal With Human Genome Sciences
    > Xencor Raises $45M
    > Xencor Raises $15M
    > Xencor In Licensing Agreement

    RSS Feed
    subscri be via emailNewsletter


    Previous news:

     Tuesday, May 13, 2008
    Monday, May 12, 2008
    Friday, May 9, 2008
    Thursday, May 8, 2008
    Wednesday, May 7, 2008